Erlizumab
Monoclonal antibody / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Erlizumab?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Erlizumab, also known as rhuMAb, is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack, stroke, and traumatic shock.[1]
Quick Facts Monoclonal antibody, Type ...
Monoclonal antibody | |
---|---|
Type | F(ab')2 fragment |
Source | Humanized (from mouse) |
Target | CD18 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG |
|
NY (what is this?) (verify) |
Close